title: Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection.
authors.forename: C
authors.initials: C
authors.lastname: Tascini
authors.forename: S
authors.initials: S
authors.lastname: Ferranti
authors.forename: A
authors.initials: A
authors.lastname: Leonildi
authors.forename: F
authors.initials: F
authors.lastname: Menichetti
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000382:microbiology; D000935:Antifungal Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy; D003586:Cytomegalovirus Infections / Q000150:complications; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D017809:Fatal Outcome; D015725:Fluconazole / Q000627:therapeutic use*; D016469:Fungemia / Q000188:drug therapy; D005670:Fusarium / Q000302:isolation & purification*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000382:microbiology*; D011014:Pneumonia / Q000382:microbiology*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole